Bronfman E.L. Rothschild L.P. Increases Stake in CME Group Inc (CME)
Bronfman E.L. Rothschild L.P. lifted its holdings in CME Group Inc (NASDAQ:CME) by 40.7% during the fourth quarter, HoldingsChannel reports. The firm owned 4,168 shares of the financial services provider’s stock after purchasing an additional 1,206 shares during the period. Bronfman E.L. Rothschild L.P.’s holdings in CME Group were worth $609,000 as of its most recent SEC filing.
A number of other institutional investors and hedge funds have also recently modified their holdings of CME. Scotia Capital Inc. acquired a new position in CME Group during the second quarter worth $211,000. Koch Industries Inc. increased its holdings in CME Group by 16,136.1% during the second quarter. Koch Industries Inc. now owns 278,612 shares of the financial services provider’s stock worth $276,000 after buying an additional 276,896 shares during the last quarter. Advisory Services Network LLC increased its holdings in CME Group by 8,266.3% during the second quarter. Advisory Services Network LLC now owns 6,944 shares of the financial services provider’s stock worth $870,000 after buying an additional 6,861 shares during the last quarter. Cetera Investment Advisers acquired a new position in CME Group during the second quarter worth $242,000. Finally, Intl Fcstone Inc. acquired a new position in CME Group during the second quarter worth $1,176,000. Institutional investors and hedge funds own 82.85% of the company’s stock.
CME Group Inc (NASDAQ CME) opened at $160.16 on Wednesday. CME Group Inc has a fifty-two week low of $114.82 and a fifty-two week high of $163.00. The company has a market cap of $54,500.00, a price-to-earnings ratio of 13.41, a price-to-earnings-growth ratio of 2.05 and a beta of 0.64. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.03 and a quick ratio of 1.05.
The business also recently disclosed a quarterly dividend, which will be paid on Monday, March 26th. Shareholders of record on Friday, March 9th will be issued a $0.70 dividend. This is an increase from CME Group’s previous quarterly dividend of $0.66. This represents a $2.80 annualized dividend and a dividend yield of 1.75%. The ex-dividend date is Thursday, March 8th. CME Group’s payout ratio is currently 22.11%.
In related news, insider Sunil Cutinho sold 2,600 shares of the company’s stock in a transaction dated Friday, November 17th. The shares were sold at an average price of $139.57, for a total value of $362,882.00. Following the transaction, the insider now directly owns 22,301 shares in the company, valued at $3,112,550.57. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, COO Julie Holzrichter sold 12,920 shares of the company’s stock in a transaction dated Tuesday, November 28th. The shares were sold at an average price of $144.08, for a total transaction of $1,861,513.60. The disclosure for this sale can be found here. Over the last quarter, insiders sold 67,128 shares of company stock worth $10,086,157. Corporate insiders own 0.57% of the company’s stock.
CME has been the topic of a number of recent analyst reports. BidaskClub upgraded shares of CME Group from a “hold” rating to a “buy” rating in a report on Tuesday, January 9th. Berenberg Bank initiated coverage on shares of CME Group in a report on Thursday, January 25th. They set a “hold” rating and a $170.00 target price on the stock. Zacks Investment Research upgraded shares of CME Group from a “hold” rating to a “buy” rating and set a $164.00 target price on the stock in a report on Tuesday, January 2nd. Goldman Sachs Group upgraded shares of CME Group from a “neutral” rating to a “buy” rating and set a $180.00 target price on the stock in a report on Wednesday, February 7th. Finally, Bank of America boosted their target price on shares of CME Group from $173.00 to $175.00 and gave the stock a “buy” rating in a report on Friday, February 2nd. Three research analysts have rated the stock with a hold rating, eleven have assigned a buy rating and one has given a strong buy rating to the company. The stock presently has an average rating of “Buy” and an average price target of $157.00.
TRADEMARK VIOLATION WARNING: This report was first reported by Watch List News and is owned by of Watch List News. If you are accessing this report on another domain, it was stolen and reposted in violation of U.S. & international copyright legislation. The legal version of this report can be read at https://www.watchlistnews.com/bronfman-e-l-rothschild-l-p-increases-stake-in-cme-group-inc-cme/1864906.html.
CME Group Profile
CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc (NASDAQ:CME).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.